425: Strive & Semler Scientific Merger Communication

Strive, Inc. board member Avik Roy reposted a communication on X.com regarding the proposed business combination with Semler Scientific, Inc.

Summary

• A communication was reposted on X.com by Avik Roy, Board Member of Strive, Inc., on September 25, 2025, concerning Strive's proposed business combination with Semler Scientific, Inc.
• The filing includes cautionary statements regarding forward-looking information related to the proposed transaction, its strategic and financial benefits, timing, and integration.
• Strive intends to file a Registration Statement on Form S-4 with the SEC, which will include an Information Statement/Proxy Statement/Prospectus for Semler Scientific stockholders.
• Semler Scientific stockholders will be asked to approve the proposed transaction, and investors are urged to review all relevant SEC filings before making voting or investment decisions.
• Strive plans to issue additional shares of its Class A common stock in connection with the proposed transaction, which will result in dilution.

Sentiment

Score: 5

Explanation: The filing is a procedural communication about a proposed merger, heavily emphasizing cautionary forward-looking statements and risks. It does not present new financial results or overwhelmingly positive/negative news, maintaining a neutral stance while outlining the process and potential challenges.

Positives

• The proposed business combination is expected to yield strategic benefits for the combined company.
• Anticipated financial benefits, including potential cost savings, are expected from the proposed transaction.

Negatives

• The proposed transaction may not close when expected or at all due to unfulfilled conditions.
• Integration of the two companies could be more difficult, time-consuming, or costly than anticipated.
• Strive's issuance of additional Class A common stock in connection with the merger will cause dilution for existing shareholders.
• Management's attention may be diverted from ongoing business operations and opportunities during the merger process.
• There is a potential for adverse reactions from customers or changes to business or employee relationships as a result of the announcement or completion of the transaction.

Risks

• The merger agreement between Strive and Semler Scientific could be terminated due to various events, changes, or circumstances.
• Conditions required for closing the proposed transaction may not be received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings instituted against Strive, Semler Scientific, or the combined company could be unfavorable.
• Anticipated benefits of the proposed transaction, including cost savings and strategic gains, may not be realized as expected or at all, partly due to risks associated with Bitcoin and other digital assets and their treasury strategies.
• The integration of the two companies may prove more difficult, time-consuming, or costly than initially projected.
• The proposed transaction could be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Management's focus may be diverted from core business operations and opportunities during the merger process.
• Strive's issuance of additional shares of its Class A common stock in connection with the transaction will result in dilution for shareholders.
• Customers of Strive or Semler Scientific may react adversely, or business and employee relationships could change following the announcement or completion of the merger.
• Changes in Strive's or Semler Scientific's share price may occur before the closing of the transaction.
• General economic and market conditions, interest and exchange rates, monetary policy, and regulatory changes could affect the combined company's future results.

Future Outlook

The filing provides a forward-looking outlook on the proposed business combination between Strive and Semler Scientific, anticipating strategic and financial benefits, including cost savings, and outlining the expected timing of the closing and the ability to integrate the businesses. However, it heavily cautions that actual results may differ materially due to inherent risks and uncertainties, and neither company commits to updating these forward-looking statements.

Management Comments

• Avik Roy, Board Member of Strive, Inc., reposted the communication on X.com on September 25, 2025.
• Management of both Strive and Semler Scientific believe their expectations regarding forward-looking statements are based upon reasonable assumptions within the bounds of their existing knowledge.

Industry Context

The explicit mention of "Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets" indicates that the combined entity or one of the constituent companies is either currently involved in or plans to engage with digital assets. This aligns with a growing trend among some public companies exploring alternative treasury management and investment strategies involving cryptocurrencies, which introduces a unique set of market and regulatory risks.

Corporate Governance

Legal Proceedings

• There is a risk regarding the outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company in connection with the proposed transaction.

Related Party Transactions

• Information about Semler Scientific's transactions with related persons is available in its definitive proxy statement for its 2025 Annual Meeting of Stockholders, filed on July 17, 2025.

Stakeholder Impact

• Shareholders: Potential dilution from Strive's issuance of additional Class A common stock; Semler Scientific shareholders will vote on the proposed transaction; potential impact on share price for both companies.
• Customers: Potential for adverse reactions or changes to business relationships.
• Employees: Potential for changes to employee relationships.
• Management: Diversion of attention from ongoing business operations and opportunities.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register the Class A common stock to be issued.
• The Registration Statement will include an Information Statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific to seek their approval of the proposed transaction.
• Investors and stockholders of Semler Scientific are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available, along with other relevant SEC documents.

Key Dates

Recommendation

This filing is a procedural update regarding a proposed merger, not a financial results announcement. While the merger itself is a significant event, this specific communication primarily outlines risks and procedural steps. Without new financial data or a clear indication of the merger's immediate value proposition beyond general 'strategic and financial benefits,' a 'hold' recommendation is appropriate for investors to await further details, particularly the comprehensive S-4 filing, before making definitive investment decisions. The numerous risks highlighted warrant caution.

Keywords

Strive, Semler Scientific, merger, business combination, SEC filing, Form 425, forward-looking statements, Bitcoin treasury, digital assets, proxy statement, corporate governance, dilution